EUVIMEDEUVIMED entdecken
Open Access

From design to functionality of ionic-liquid-related salts: DNA titration, antioxidants, and anticancer activities

Salim Ali, Ming-Fa Hsieh, Zheng-Yuan Su, Mouslim Messali, Noureddine El Messaoudi, Shilpi Khurana, Imran Ali

Future Medicinal Chemistry · 2026

DOI: 10.1080/17568919.2026.2714030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Salim Ali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Jamia Millia Islamia (Central University), New Delhi, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Antioxidants, Ionic Liquids, DNA. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: To develop effective functional ionic-liquid-related salts (ILRSs) as future anticancer drugs. MATERIALS AND METHODS: Twelve imidazole-based ionic-liquid-related salts were synthesized and characterized by spectroscopic methods. These ILRSs were used to study the antioxidant and anticancer activities, DNA titration, modeling, and in-silico studies. RESULTS: Among 12 ILRSs, ILRSs 5 and 4 indicated superior activities, showing higher scavenging percentages (70.7% and 65.5%) and lower IC50 values than the standard ascorbic acid. ILRSs 5 and 4 showed the most effective activities with MCF-7 cells, with viability values of 52.17% and 53.67% at 10 µM and IC50 values of 10.87 and 11.03 µM, respectively. DNA-binding studies showed moderate to strong interactions with Ct-DNA (binding constants: 104 to 105 M-1). The modeling studies of compounds A and B with DNA confirmed one hydrogen bond with -8.7 and -8.2 kcal/mol binding affinities. CONCLUSIONS: The reported ILRSs 5 and 4 showed good antioxidant and anticancer activities and may be used as future anticancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAntioxidantsIonic LiquidsDNADrug DesignImidazolesHumansSaltsMCF-7 CellsCell SurvivalDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureBiphenyl CompoundsPicrates

Stichwörter der Autor:innen

DNA titration and modelingImidazole-based ionic-liquid-related saltsantioxidant and anticancer activitiescharacterizationin-silico studies

Substanzen

Antineoplastic AgentsAntioxidantsIonic LiquidsDNASaltsImidazolesBiphenyl CompoundsPicrates

Autor:innen und Institutionen

  • Department of Chemistry, Jamia Millia Islamia (Central University), New Delhi, India.
  • Department of Biomedical Sciences and Engineering, Tzu Chi University, Hualien City, Taiwan (R.O.C.).
  • Department of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City, Taiwan (R.O.C.).
  • Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan City, Taiwan (R.O.C.).
  • Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
  • Department of Chemistry, Deshbandhu College (University of Delhi), Kalkaji, India.

Zitieren

APA

Ali, S., Hsieh, M. F., Su, Z. Y., Messali, M., El Messaoudi, N., Khurana, S., & Ali, I. (2026). From design to functionality of ionic-liquid-related salts: DNA titration, antioxidants, and anticancer activities. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2714030

Vancouver

Ali S, Hsieh MF, Su ZY, Messali M, El Messaoudi N, Khurana S, et al. From design to functionality of ionic-liquid-related salts: DNA titration, antioxidants, and anticancer activities. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2026.2714030

BibTeX
@article{Ali2026,
  author = {Ali, Salim and Hsieh, Ming-Fa and Su, Zheng-Yuan and Messali, Mouslim and El Messaoudi, Noureddine and Khurana, Shilpi and Ali, Imran},
  title = {From design to functionality of ionic-liquid-related salts: DNA titration, antioxidants, and anticancer activities},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  doi = {10.1080/17568919.2026.2714030}
}
Kostenlos starten →